DK0621898T3 - Kimæriske immunogener - Google Patents
Kimæriske immunogenerInfo
- Publication number
- DK0621898T3 DK0621898T3 DK93901988T DK93901988T DK0621898T3 DK 0621898 T3 DK0621898 T3 DK 0621898T3 DK 93901988 T DK93901988 T DK 93901988T DK 93901988 T DK93901988 T DK 93901988T DK 0621898 T3 DK0621898 T3 DK 0621898T3
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- piv
- rsv
- gene sequence
- pathogen
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 3
- 244000052769 pathogen Species 0.000 abstract 3
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
- G01N2333/135—Respiratory syncytial virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929200117A GB9200117D0 (en) | 1992-01-06 | 1992-01-06 | Production of recombinant chimeric proteins for vaccine use |
PCT/CA1993/000001 WO1993014207A1 (en) | 1992-01-06 | 1993-01-05 | Chimeric immunogens |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0621898T3 true DK0621898T3 (da) | 2001-11-12 |
Family
ID=10708117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93901988T DK0621898T3 (da) | 1992-01-06 | 1993-01-05 | Kimæriske immunogener |
Country Status (16)
Country | Link |
---|---|
US (13) | US6225091B1 (da) |
EP (1) | EP0621898B1 (da) |
JP (1) | JP3290662B2 (da) |
KR (1) | KR100208310B1 (da) |
AT (1) | ATE205535T1 (da) |
AU (1) | AU667502B2 (da) |
CA (1) | CA2126863C (da) |
DE (1) | DE69330745T2 (da) |
DK (1) | DK0621898T3 (da) |
ES (1) | ES2164070T3 (da) |
FI (1) | FI117514B (da) |
GB (1) | GB9200117D0 (da) |
NO (1) | NO316622B1 (da) |
PT (1) | PT621898E (da) |
RU (1) | RU2123047C1 (da) |
WO (1) | WO1993014207A1 (da) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
FR2718452B1 (fr) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
US6300090B1 (en) | 1994-07-29 | 2001-10-09 | The Rockefeller University | Methods of use of viral vectors to deliver antigen to dendritic cells |
US20030054505A1 (en) * | 1997-09-26 | 2003-03-20 | Hong Jin | Recombinant rsv expression systems and vaccines |
FR2726472B1 (fr) | 1994-11-07 | 1997-01-31 | Pf Medicament | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin |
US7485440B2 (en) | 1995-09-27 | 2009-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
US6699476B1 (en) | 1996-07-15 | 2004-03-02 | Peter L. Collins | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
BRPI9710363B8 (pt) | 1996-07-15 | 2021-07-06 | Us Gov Health & Human Serv | partìcula de vìrus sincicial respirátorio recombinante (rsv) infeccioso atenuado, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante (rsv), vetor de expressão, e, método de produção de um vìrus sincicial respiratório recombinante (rsv) infeccioso. |
FR2751229B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
US6410023B1 (en) | 1997-05-23 | 2002-06-25 | United States Of America | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
US7250171B1 (en) | 1997-05-23 | 2007-07-31 | United States Of America As Represented By The Dept. Of Health & Human Services | Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein |
US20030082209A1 (en) | 2000-07-05 | 2003-05-01 | Skiadopoulos Mario H. | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
US7192593B2 (en) * | 1997-05-23 | 2007-03-20 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
US7632508B2 (en) | 1997-05-23 | 2009-12-15 | The United States Of America | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
US7314631B1 (en) | 1997-05-23 | 2008-01-01 | The United States Of America As Represented By The Department Of Health And Human Services | Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) |
US7201907B1 (en) | 1997-05-23 | 2007-04-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines |
US7951383B2 (en) | 1997-05-23 | 2011-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated parainfluenza virus (PIV) vaccines |
US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
AU5980899A (en) * | 1998-09-25 | 2000-04-17 | Smithkline Beecham Biologicals (Sa) | Novel compounds |
KR100940776B1 (ko) * | 1999-07-09 | 2010-02-11 | 더 가버먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 리프리젠티드 바이 더 디파트먼트 오브 헬스 앤 휴먼 서비씨즈 | 약독화된 사람-소 키메라 파라인플루엔자바이러스(piv) 백신 |
WO2001004335A2 (en) | 1999-07-09 | 2001-01-18 | The Government Of The United States Of America, As Represented By The Department Of Health And Humanservices | Human-bovine chimeric respiratory syncytial virus vaccines |
US6764685B1 (en) | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
US20030232055A1 (en) * | 2000-07-31 | 2003-12-18 | Ruslan Medzhitov | Innate immune system-directed vaccines |
US20030175287A1 (en) * | 2001-01-03 | 2003-09-18 | Yale University | Innate immune system-directed vaccines |
IL157003A0 (en) | 2001-01-19 | 2004-02-08 | Vironovative Bv | A virus causing respiratory tract illness in susceptible mammals |
US8715922B2 (en) | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
CN1646684B (zh) | 2002-02-21 | 2010-10-06 | 免疫医疗疫苗公司 | 重组副流感病毒表达系统以及包含源自间质肺病毒的异种抗原的疫苗 |
CA2484538C (en) * | 2002-04-30 | 2014-03-25 | Dnavec Research Inc. | Vectors with modified protease-dependent tropism |
CA2494485A1 (en) * | 2002-07-25 | 2004-02-05 | Medimmune, Inc. | Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
WO2004066961A2 (en) * | 2003-01-20 | 2004-08-12 | St. Jude Children's Research Hospital | Use of sendai virus as a human parainfluenza vaccine |
DE602004027362D1 (de) * | 2003-03-28 | 2010-07-08 | Medimmune Llc | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 |
CN101410519B (zh) | 2003-04-25 | 2013-04-24 | 免疫医疗有限责任公司 | 间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法 |
MY157941A (en) * | 2005-01-19 | 2016-08-15 | Vaxinnate Corp | Compositions of pathogen-associated molecular patterns and methods of use |
EP1991264B1 (en) | 2006-03-07 | 2015-01-07 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
DE102006060799A1 (de) | 2006-12-21 | 2008-06-26 | RUHR-UNIVERSITäT BOCHUM | RSV F-Protein und seine Verwendung |
US8445663B2 (en) | 2009-02-02 | 2013-05-21 | Chrontech Pharma Ab | Compositions and methods that enhance an immune response |
SG176807A1 (en) * | 2009-06-24 | 2012-01-30 | Id Biomedical Corp Quebec | Vaccine |
AU2012211126A1 (en) * | 2011-01-28 | 2013-07-18 | Medimmune, Llc | Expression of soluble viral fusion glycoproteins in mammalian cells |
WO2013031827A1 (ja) | 2011-08-29 | 2013-03-07 | 国立大学法人徳島大学 | Rsv粘膜ワクチン |
ES2894724T3 (es) | 2011-12-02 | 2022-02-15 | Rhode Island Hospital | Vacuna contra la malaria falciparum |
EA201891945A3 (ru) | 2012-08-01 | 2019-05-31 | Бавариан Нордик А/С | Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv) |
WO2014186409A1 (en) | 2013-05-15 | 2014-11-20 | Chrontech Pharma Ab | Immunogenic compositions for inhibiting hepatitis d virus |
EP4011451A1 (en) | 2015-10-22 | 2022-06-15 | ModernaTX, Inc. | Metapneumovirus mrna vaccines |
US11103578B2 (en) | 2016-12-08 | 2021-08-31 | Modernatx, Inc. | Respiratory virus nucleic acid vaccines |
MA47790A (fr) | 2017-03-17 | 2021-05-05 | Modernatx Inc | Vaccins à base d'arn contre des maladies zoonotiques |
US11351242B1 (en) | 2019-02-12 | 2022-06-07 | Modernatx, Inc. | HMPV/hPIV3 mRNA vaccine composition |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4722848A (en) * | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
US5110587A (en) * | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
US4866034A (en) * | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
SE8205892D0 (sv) * | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
EP0175261B1 (en) * | 1984-09-12 | 1991-12-11 | Chiron Corporation | Hybrid particle immunogens |
US4722898A (en) * | 1985-04-29 | 1988-02-02 | Minnesota Mining And Manufacturing Company | Immobilization of biological cells in polytetrafluoroethylene matrix |
GB8610983D0 (en) * | 1986-05-06 | 1986-06-11 | Connaught Lab | Enhancement of antigen immunogenicity |
US4879213A (en) * | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
US5098998A (en) * | 1987-04-29 | 1992-03-24 | President And Fellows Of Harvard College | Cholera vaccines and peptides |
ATE87487T1 (de) * | 1987-11-16 | 1993-04-15 | Hoffmann La Roche | Rekombinante hiv-2 polypeptide. |
AU617739B2 (en) * | 1987-12-23 | 1991-12-05 | Pharmacia & Upjohn Company | Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
EP0413695B1 (en) * | 1988-04-22 | 1994-05-04 | The Upjohn Company | Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
FR2636842B1 (fr) | 1988-09-27 | 1994-06-10 | Liege Universite Etat | Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion |
EP0421626A1 (en) | 1989-09-19 | 1991-04-10 | Merck & Co. Inc. | Vaccine for aids and hepatitis B |
GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
IL105456A (en) | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
-
1992
- 1992-01-06 GB GB929200117A patent/GB9200117D0/en active Pending
-
1993
- 1993-01-05 CA CA002126863A patent/CA2126863C/en not_active Expired - Lifetime
- 1993-01-05 DE DE69330745T patent/DE69330745T2/de not_active Expired - Lifetime
- 1993-01-05 RU RU94042722A patent/RU2123047C1/ru active
- 1993-01-05 KR KR1019940702329A patent/KR100208310B1/ko not_active IP Right Cessation
- 1993-01-05 PT PT93901988T patent/PT621898E/pt unknown
- 1993-01-05 ES ES93901988T patent/ES2164070T3/es not_active Expired - Lifetime
- 1993-01-05 AT AT93901988T patent/ATE205535T1/de active
- 1993-01-05 EP EP93901988A patent/EP0621898B1/en not_active Expired - Lifetime
- 1993-01-05 WO PCT/CA1993/000001 patent/WO1993014207A1/en active IP Right Grant
- 1993-01-05 JP JP51203593A patent/JP3290662B2/ja not_active Expired - Lifetime
- 1993-01-05 AU AU33402/93A patent/AU667502B2/en not_active Expired
- 1993-01-05 DK DK93901988T patent/DK0621898T3/da active
- 1993-01-06 US US08/001,554 patent/US6225091B1/en not_active Expired - Lifetime
-
1994
- 1994-07-05 NO NO19942530A patent/NO316622B1/no not_active IP Right Cessation
- 1994-07-05 FI FI943211A patent/FI117514B/fi not_active IP Right Cessation
- 1994-11-14 US US08/344,639 patent/US6033668A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/467,969 patent/US6168786B1/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,963 patent/US5968776A/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,961 patent/US6171783B1/en not_active Expired - Lifetime
-
1997
- 1997-04-16 US US08/838,189 patent/US5998169A/en not_active Expired - Lifetime
- 1997-05-07 US US08/852,344 patent/US6017539A/en not_active Expired - Lifetime
-
2004
- 2004-05-10 US US10/842,032 patent/US7244589B2/en not_active Expired - Fee Related
-
2007
- 2007-06-13 US US11/808,800 patent/US7405273B2/en not_active Expired - Fee Related
- 2007-06-13 US US11/808,802 patent/US7498153B2/en not_active Expired - Fee Related
- 2007-06-13 US US11/808,794 patent/US7671186B2/en not_active Expired - Fee Related
- 2007-06-13 US US11/808,789 patent/US7619063B2/en not_active Expired - Fee Related
- 2007-06-13 US US11/808,807 patent/US7514535B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0621898T3 (da) | Kimæriske immunogener | |
DK0612250T3 (da) | Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener | |
EP0855918A4 (en) | INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF | |
BG98523A (en) | Hla-limited cytotoxic t-lymphocytic (ctl) epitopes of the virus of hepatite b | |
DE69333468D1 (de) | Schützende antikörper induzierende antigene aus plasmodium falciparum | |
DK0759067T3 (da) | Transformerende vækstfaktor alfa-H1 | |
FI903154A0 (fi) | Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus. | |
DK251890D0 (da) | Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering | |
MX9802285A (es) | Vacunas y glicoproteinas de virus de parainfluenza. | |
DK22389A (da) | Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma | |
ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
ATE342920T1 (de) | Methylierte smd homologe peptide, die mit antikörpern aus sera von lebewesen mit systemischer lupus erythematodes reagieren | |
DK482788D0 (da) | Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae | |
AU626684B2 (en) | Mouse monoglonal antibodies for post-exposure treatment of rabies | |
ATE201693T1 (de) | Hämoregulierende peptide | |
DK0762895T3 (da) | Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
ATE107661T1 (de) | Hrsv-vakzine. | |
DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
DE69619123D1 (de) | Hämoregulatorische verbindungen |